STOCK TITAN

CalciMedica officer reports 50,000-share stock option

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

CalciMedica, Inc. (CALC) Chief Accounting Officer Sean Patrick Lawler reported 12 directly held employee stock-option positions tied to common stock. The listed options have exercise prices from $1.74 to $86.70, and reported underlying-share counts from 11 to 50,000 per option entry.

Insider Lawler Sean Patrick
Role Chief Accounting Officer
Type Security Shares Price Value
Holding Employee Stock Option (Right to Buy) F1 -- -- --
Holding Employee Stock Option (Right to Buy) F1 -- -- --
Holding Employee Stock Option (Right to Buy) F1 -- -- --
Holding Employee Stock Option (Right to Buy) F1 -- -- --
Holding Employee Stock Option (Right to Buy) F2 -- -- --
Holding Employee Stock Option (Right to Buy) F1 -- -- --
Holding Employee Stock Option (Right to Buy) F3 -- -- --
Holding Employee Stock Option (Right to Buy) F4 -- -- --
Holding Employee Stock Option (Right to Buy) F4 -- -- --
Holding Employee Stock Option (Right to Buy) F5 -- -- --
Holding Employee Stock Option (Right to Buy) F6 -- -- --
Holding Employee Stock Option (Right to Buy) F7 -- -- --
Holdings: Employee Stock Option (Right to Buy) — 80,496 options (Direct)
Footnotes (7)
  1. F1. Immediately exercisable.
  2. F2. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following November 22, 2022.
  3. F3. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following May 8, 2023.
  4. F4. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following March 28, 2024.
  5. F5. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following March 26, 2025.
  6. F6. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following April 1, 2025.
  7. F7. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following September 24, 2026.
Underlying shares 50,000 shares Employee stock option expiring September 23, 2036
Exercise price $1.74 per share Employee stock option expiring September 23, 2036
Underlying shares 12,000 shares Employee stock option expiring April 22, 2035
Exercise price $7.65 per share Employee stock option expiring April 22, 2035
Underlying shares 6,251 shares Employee stock option expiring April 4, 2036
Exercise price $2.9250 per share Employee stock option expiring April 4, 2036
Underlying shares 4,000 shares Employee stock option expiring March 27, 2034
Exercise price $20.80 per share Employee stock option expiring March 27, 2034
Employee Stock Option (Right to Buy) technical
"Employee Stock Option (Right to Buy)"
vesting financial
"shares subject to the option vest in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion or exercise price of $1.7400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What options did CalciMedica (CALC) Chief Accounting Officer Sean Patrick Lawler report?

Sean Patrick Lawler reported directly held employee stock options, including one covering 50,000 underlying common shares at a $1.74 exercise price, expiring September 23, 2036. Those shares vest in equal monthly installments over four years following September 24, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Lawler Sean Patrick

(Last)(First)(Middle)
C/O CALCIMEDICA, INC.
505 COAST S. BLVD, SUITE 300-9

(Street)
LA JOLLA CALIFORNIA 92037

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
11/10/2026
3. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. [ CALC ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy) (1)11/08/2020Common Stock1,177$33D
Employee Stock Option (Right to Buy) (1)04/27/2031Common Stock139$39.95D
Employee Stock Option (Right to Buy) (1)06/30/2031Common Stock139$39.95D
Employee Stock Option (Right to Buy) (1)08/30/2032Common Stock11$52.1D
Employee Stock Option (Right to Buy) (2)03/19/2033Common Stock376$86.7D
Employee Stock Option (Right to Buy) (1)03/19/2033Common Stock2$86.7D
Employee Stock Option (Right to Buy) (3)05/07/2033Common Stock2,401$16.25D
Employee Stock Option (Right to Buy) (4)03/27/2034Common Stock4,000$20.8D
Employee Stock Option (Right to Buy) (4)08/26/2034Common Stock4,000$20.8D
Employee Stock Option (Right to Buy) (5)04/22/2035Common Stock12,000$7.65D
Employee Stock Option (Right to Buy) (6)04/04/2036Common Stock6,251$2.925D
Employee Stock Option (Right to Buy) (7)09/23/2036Common Stock50,000$1.74D
Explanation of Responses:
1. Immediately exercisable.
2. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following November 22, 2022.
3. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following May 8, 2023.
4. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following March 28, 2024.
5. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following March 26, 2025.
6. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following April 1, 2025.
7. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following September 24, 2026.
/s/ Sean Patrick Lawler11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading